Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Attention-gated 3D CapsNet for robust hippocampal segmentation.
Poiret C, Bouyeure A, Patil S, Boniteau C, Duchesnay E, Grigis A, Lemaitre F, Noulhiane M. Poiret C, et al. Among authors: lemaitre f. J Med Imaging (Bellingham). 2024 Jan;11(1):014003. doi: 10.1117/1.JMI.11.1.014003. Epub 2024 Jan 2. J Med Imaging (Bellingham). 2024. PMID: 38173654
Risk profiles of elite breath-hold divers.
Allinger J, Noulhiane M, Féménias D, Louvet B, Clua E, Bouyeure A, Lemaître F. Allinger J, et al. Among authors: lemaitre f. Int J Environ Health Res. 2024 Jun 20:1-13. doi: 10.1080/09603123.2024.2368718. Online ahead of print. Int J Environ Health Res. 2024. PMID: 38899970
Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Masuda S, Lemaitre F, Barten MJ, Bergan S, Shipkova M, van Gelder T, Vinks S, Wieland E, Bornemann-Kolatzki K, Brunet M, de Winter B, Dieterlen MT, Elens L, Ito T, Johnson-Davis K, Kunicki PK, Lawson R, Lloberas N, Marquet P, Millan O, Mizuno T, Moes DJAR, Noceti O, Oellerich M, Pattanaik S, Pawinski T, Seger C, van Schaik R, Venkataramanan R, Walson P, Woillard JB, Langman LJ. Masuda S, et al. Among authors: lemaitre f. Ther Drug Monit. 2024 Sep 25. doi: 10.1097/FTD.0000000000001250. Online ahead of print. Ther Drug Monit. 2024. PMID: 39331837
A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir.
Lemaitre F, Boland L, Tron C, Grégoire M, Lelong-Boulouard V, Gandia P, Goirand F, Gambier N, Boglione-Kerrien C, Franck B, Lalanne S, Devresse A, Briol S, Haufroid V, Verdier MC; SFPT Therapeutic Drug Monitoring, Treatment Personalization group (STP-PT) of the French Society of Pharmacology, Therapeutics (SFPT). Lemaitre F, et al. Therapie. 2024 Jul 26:S0040-5957(24)00081-7. doi: 10.1016/j.therap.2024.07.003. Online ahead of print. Therapie. 2024. PMID: 39174455
399 results